Healthcare & Medical Devices Global On demand · 24-48h

Global Bacterial Enteric Disease Testing Market Strategic Research Report

Global Bacterial Enteric Disease Testing Market Strategic Re…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Bacterial Enteric Disease Testing Market
$3.27B2025
3.8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Reagents and Consumables, Equipment

By Application: Academic and Research Institutes, Hospital Laboratories, Pharmaceutical and Biotechnology Companies

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Becton Dickinson & Company, Bio-Rad Laboratories, Inc, Biomerieux SA, Quest Diagnostics Inc, Diasorin S.p.A., Meridian Bioscience Inc, Abbott Laboratories, Trinity Biotech, Coris BioConcept, Biomerica, Inc., Cepheid

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 119 pages
Market size 2025
$3.27B
Billion USD
Forecast CAGR
3.8%
2025-2032
Forecast 2032
$4.2B
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global Bacterial Enteric Disease Testing market size is predicted to grow from US$ 3,274 million in 2025 to US$ 4,241 million in 2032; it is expected to grow at a CAGR of 3.8% from 2026 to 2032.

Enteric diseases are infections that affect the gastrointestinal tract, which includes the stomach, small intestine, and large intestine. These diseases can be caused by various microorganisms such as bacteria, viruses, or parasites. Some common examples of enteric diseases include Clostridium difficile (C. difficile), campylobacteriosis, cholera, Escherichia coli (E. coli), Helicobacter pylori (H. pylori), salmonellosis, shigellosis, norovirus, rotavirus, amebiasis, cryptosporidiosis, and giardiasis. Various laboratory tests are used to diagnose enteric diseases and identify the specific pathogen causing an enteric disease. These tests typically involve analyzing samples of stool, blood, or other bodily fluids for the presence of enteric pathogens, such as bacteria, viruses, and parasites.

The surge in incidence rate of shigellosis, clostridium difficile (C. difficile), campylobacteriosis, cholera, Escherichia coli (E. coli), salmonellosis, and cholera, which may further cause severe diarrhea or death, drive the growth of the enteric disease testing market size. For instance, according to research article “The burden of diarrhea, etiologies, and risk factors in India from 1990 to 2019: evidence from the global burden of disease study” published in 2022, in India, the total number of deaths of all ages was 632,344 in 2019 and the mortality rate is 45 per 100,000 population.

This report presents a comprehensive overview of the global Bacterial Enteric Disease Testing market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Reagents and Consumables
  • Equipment

Segment by Application

  • Academic and Research Institutes
  • Hospital Laboratories
  • Pharmaceutical and Biotechnology Companies

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Bacterial Enteric Disease Testing market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Academic and Research Institutes, Hospital Laboratories, Pharmaceutical and Biotechnology Companies evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Bacterial Enteric Disease Testing Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 3.8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$3.27B
2025
Forecast
$4.2B
2032
CAGR
3.8%
2025–2032
영역들
5
global
Key companies
Becton Dickinson & CompanyBio-Rad Laboratories, IncBiomerieux SAQuest Diagnostics IncDiasorin S.p.A.Meridian Bioscience IncAbbott LaboratoriesTrinity Biotech
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Reagents and ConsumablesEquipment
By Application
Academic and Research InstitutesHospital LaboratoriesPharmaceutical and Biotechnology Companies

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Reagents and Consumables
  • 3.1.3 Equipment
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Academic and Research Institutes
  • 4.1.3 Hospital Laboratories
  • 4.1.4 Pharmaceutical and Biotechnology Companies
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Becton Dickinson & Company
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Bio-Rad Laboratories, Inc
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Biomerieux SA
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Quest Diagnostics Inc
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Diasorin S.p.A.
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Meridian Bioscience Inc
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Abbott Laboratories
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Trinity Biotech
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Coris BioConcept
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Biomerica, Inc.
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Cepheid
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Bacterial Enteric Disease Testing market size?
The global Bacterial Enteric Disease Testing market is estimated at US$ 3.27 billion in 2025 (base year) and is projected to reach US$ 4.24 billion by 2032.
What growth rate is expected for the Bacterial Enteric Disease Testing market through 2032?
The market is expected to grow at a CAGR of 3.8% from 2026 to 2032, expanding from US$ 3.27 billion in 2025 to US$ 4.24 billion in 2032, roughly 1.3 times its base-year value.
How is Bacterial Enteric Disease Testing defined?
Enteric diseases are infections that affect the gastrointestinal tract, which includes the stomach, small intestine, and large intestine. These diseases can be caused by various microorganisms such as bacteria, viruses, or parasites. Some common examples of enteric diseases include Clostridium difficile (C. difficile), campylobacteriosis, cholera, Escherichia coli (E. coli), Helicobacter pylori (H. pylori), salmonellosis, shigellosis, norovirus, rotavirus, amebiasis, cryptosporidiosis, and giardiasis.
How is the Bacterial Enteric Disease Testing market segmented by type?
By type, the market is segmented into Reagents and Consumables and Equipment.
What are the key applications of Bacterial Enteric Disease Testing?
Key applications covered include Academic and Research Institutes, Hospital Laboratories and Pharmaceutical and Biotechnology Companies.
Which companies are profiled in the Bacterial Enteric Disease Testing market report?
Key players profiled include Becton Dickinson & Company, Bio-Rad Laboratories, Biomerieux SA, Quest Diagnostics Inc, Diasorin S.p.A., Meridian Bioscience Inc, Abbott Laboratories and Trinity Biotech, among 11 companies covered in total.
What geographies does the Bacterial Enteric Disease Testing market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Bacterial Enteric Disease Testing market report?
The report is intended for manufacturers and solution providers, distributors and end users in Academic and Research Institutes, Hospital Laboratories and Pharmaceutical and Biotechnology Companies, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Bacterial Enteric Disease Testing market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.